alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Resulting from International Agreements

# RELAP5/MOD3.2 Post Test Analysis and Accuracy Quantification of Lobi Test BL–44 (NUREG/IA-0153)

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG/IA-0153 (PDF 5.08 MB)

## Publication Information

**Date Published:** February 1999

**Prepared by:** F. D'Auria M. Frogheri* W. Giannotti

**Prepared as part of:** The Agreement on Research Participation and Technical Exchange under the International Code Application and Maintenance Program (CAMP)

Office of Nuclear Regulatory Research U.S. Nuclear Regulatory Commission Washington, DC 20555-0001

Availability Notice

## Abstract

The present document deals with the Relap5/Mod3.2 analysis of the small break LOCA experiment BL-44 performed in LOBI/MOD2 facility.

LOBI/MOD2 was a PWR simulator (Integral Test Facility) installed at JRC (Joint Research Center) in Ispra Establishment (I). Volume scaling and core power scaling factors are 1/712, with respect to the KWU Siemens 1300 MWe (3900 MWt) standard reactor.

The expeiment is originated by a small break in the cold leg (2" equivalent break area in the plant) without the actuation of the high pressure injection system. Low pressure injection system actuation occurs after core dry-out and accumulators intervention is foreseen when primary pressure falls below 4 MPa.

The Relap5 code has been extensively used at University of Pisa; the nodalization of LOBI facility has been qualified through the application of the version Relap5/Mod2 to the same experiment and another test performed in the same facility.

Sensitivity analyses have been addressed to the influence of several parameters (like discharge break coefficient, time of accumulators start etc.) upon the predicted transient evolution.

Qualitative and quantitative code calculation accuracy evaluation has been performed.

Page Last Reviewed/Updated Tuesday, March 09, 2021
EXHIBIT 31(i).2

Certification required by Rule 13a-14(a) and 15d-14(a)

I, Robert E. Brummels, Treasurer and Principal Financial
Officer, certify that:

1. I have reviewed this annual report on Form 10-K/A of Husker Ag, LLC;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my
knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;

4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the
registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over
financial reporting; and

5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date: April 28, 2006.



|    |  |                                                                         
|--- |  | ------------------------------------------------------------------------
|By: |  | /s/ Robert E. Brummels                                                  
|    |  | Robert E. Brummels, Treasurer and Director (Principal Financial Officer)
218.928
EXHIBIT 32.1 Certification Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 In connection
with the filing of the Annual Report on Form 10-K for the year ended December
31, 2009 as filed with the Securities and Exchange Commission (the Report) by
HASCO Medical, Inc. (the Registrant), I, Hal Compton, Jr., Chief Executive
Officer of the Registrant, hereby certify that: 1.
 The Report
 fully complies with the requirements of section 13(a) or 15(d) of the
 Securities Exchange Act of 1934, as amended, and2.
 The
 information contained in the Report fairly presents, in all material
 respects, the financial conditions and results of operations of Registrant.  /s/ Hal
 Compton, Jr.Name: Hal
 Compton, Jr.Title: Chief
 Executive Officer, principal executive officer Dated: March
31, 2010 A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement has been
provided to the company and will be retained by the company and furnished to
the Securities and Exchange Commission or its staff upon request.
No. 86-1095.

#### Kohrig *v.*Illinois.

Appeal from Sup. Ct. Ill. dismissed for want of substantial federal question.
HomeNRC LibraryDocument CollectionsNUREG-Series PublicationsPublications Resulting from International Agreements

# Model 3D Cores for PWR Using Vessel Components in TRACEv5.OP3 (NUREG/IA-0460)

On this page:
        - Publication Information
        - Abstract

Download complete document
        - NUREG/IA-0460 (PDF - 4.08 MB)

## Publication Information

**Manuscript Completed:**September 2015**Date Published:** January 2016

**Prepared by:** C. Mesado, R. Miró, T. Barrachina, G. Verdú

Institute for Industrial, Radiophysical and Environmental Safety (ISIRYM) Universitat Politècnica de València Camí de Vera, s/n 46021 Valencia, SPAIN

K. Tien, NRC Project Manager

Division of Systems Analysis Office of Nuclear Regulatory Research U.S. Nuclear Regulatory Commission Washington, DC 20555-0001

**Prepared as part of:** The Agreement on Research Participation and Technical Exchange Under the Thermal-Hydraulic Code Applications and Maintenance Program (CAMP)

**Published by:** U.S. Nuclear Regulatory Commission Washington, DC 20555-0001 

Availability Notice

## Abstract

New models for Pressurized Water Reactor (PWR) with fully 3D cores were developed using TRACE thermal-hydraulic code. To develop these new models, TRACE code was chosen because it is been developed and will be probably licensed by the Nuclear Regulatory Commission (NRC). Thus, it is easy to take advantage of current and future features of TRACE. Three 3D different models were developed, they make use of the 3D vessel component in TRACE, either cartesian or cylindrical type. These models are especially suitable to simulate cross-flow, instabilities and in general asymmetric phenomena. All three models have been successfully tested.

Page Last Reviewed/Updated Tuesday, March 09, 2021
No. 90-6112.

#### Felton *v.*Barnett et al.

C. A. 4th Cir. Certiorari denied.
HomeNRC LibraryDocument CollectionsNews Releases2000

# NRC Approves Transfer of Operating License for Oyster Creek to Amergen Energy Company

----

----

**NRC APPROVES TRANSFER OF OPERATING LICENSE FOR OYSTER CREEK TO AMERGEN ENERGY COMPANY**

The Nuclear Regulatory Commission has approved the transfer of Oyster Creek Nuclear Generating Station's operating license from GPU Nuclear, Inc., and Jersey Central Power & Light Company to AmerGen Energy Company.

Oyster Creek is located near Toms River, New Jersey.

GPU Nuclear, Inc., and Jersey Central Power & Light Company are wholly-owned subsidiaries of GPU, Inc. AmerGen is owned in equal shares by PECO Energy Company and British Energy, Inc.

On November 5, 1999, GPU Nuclear and AmerGen jointly submitted an application to the NRC requesting approval for the license transfer. The key issues considered by the NRC staff included foreign ownership, decommissioning funding, insurance, and AmerGen's technical and financial qualifications.

On January 5, the Nuclear Information Resource Service (NIRS) filed a petition to intervene and request for a hearing, raising questions about AmerGen's financial qualifications, the extent of its nuclear experience, antitrust considerations, decommissioning funding and physical changes to the plant.

On May 3, the Commission ruled that although NIRS had demonstrated standing as an intervenor, it had failed to raise any admissible issues. Separately, the staff concluded that AmerGen is financially qualified to own, operate and decommission Oyster Creek, and technically qualified to operate the plant.

This license transfer review is similar to others conducted by the NRC in conjunction with the acquisition by AmerGen of Three Mile Island Unit 1, in Pennsylvania, and the Clinton nuclear power station in Illinois. The staff is currently reviewing a license transfer request submitted by a subsidiary of AmerGen for the Vermont Yankee nuclear plant.

Page Last Reviewed/Updated Wednesday, March 24, 2021
No. 82-5957.

#### Easterwood *v.*Oklahoma.

Ct. Crim. App. Okla. Certiorari denied.
#### John Barnes *v.*Turner Dickinson,

From Wayne.

Detinue, tried before his itonor, Judge Donnere, and aft, r a verdict for the Defendant, the Plaintiff moved for a new trial upon the following grounds :

1st. That one *Cooke,*who had been examined as a witness .for the Defendant, was interested in the event of the *347cause, and that this interest was not discovered by the Plaintiff, until after the Jury had returned their verdict.

• 2d. That the Deposition of oue *Rebecca. Hicks*had been read for the Defendant, which was in the handwriting of the witness *Cooke.*

3d. That the witness *Rebecca Hicks,*had declared to the Plaintiff before the trial of the suit, that she was illiterate, and knew nothing of the contents of the deposition.

The Defendant filed the affidavit of *Cooke,*the witness, who swore that the only way in which he was interested in the cause, arose from the fact that his father was the bail of the Defendant, and that his father was still alive. His Honor discharged tlie rule, and the Plaintiff appealed.

The case was submitted by *Gaston,*for the Plaintiff, and by *Badger,*for the Defendant.

Hax.Ii, Judge.

It does not appear that Cooke had such an interest in the cause as to render him incompetent.

As to what *Rebecca Hicks*tol$ the Plaintiff, relative to her deposition, he had ample time to avail himself of it (if that could be done) on the trial ¿ he might also then have objected to her deposition, because it was in the handwriting of *Cooke,*if that objection would have availed him. I think the Judge did right in not granting a new trial for these reasons.

Per Curiam. — Judgment affirmed.
**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Inconnection with the quarterly report of Pharmaceutical Product Development, Inc. (“PPD”) on Form 10-Q for the period ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the“Report”), I, Daniel G. Darazsdi, Chief Financial Officer of PPD, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of PPD as of, andfor, the periods presented in the Report. 

Date: November 5, 2008
STEAM ELECTRIC CBI REPLACEMENT PAGE EPA-HQ-OW-2009-0819

DCN: SE03520
THE FOLLOWING HAS BEEN REMOVED BECAUSE IT CONTAINS CONFIDENTIAL BUSINESS INFORMATION (CBI) PER 40 CFR PART 2, SUBPART B.
**Exhibit 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO**

**18 U.S.C. SECTION 1350**

In connection withthe Quarterly Report of Zoran Corporation (the “Company”) on Form 10-Q for theperiod ended June 30, 2006, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Karl Schneider, Senior VicePresident, Finance and Chief Financial Officer of the Company, hereby certify,pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 ofthe Sarbanes-Oxley Act of 2002, that:

(1)  TheReport fully complies with the requirements of Section 13(a) of the SecuritiesExchange Act of 1934; and

(2)  Theinformation contained in the Report fairly presents, in all material respects,the financial condition and result of operations of the Company.
| Dated: April 19, 2007 | /s/ Karl Schneider                 |   |
|----------------------------|------------------------------------|--------|
|                       | Karl Schneider                     |
|                       | Senior Vice President, Finance and |
|                       | Chief Financial Officer            |

 

----
### I
. OFFICEOFTHEATTORNEYGENERALOFTEXAS **AUSTIN**

EoonorableGeo. H, Sheppard **$ e**  comptroller of Fublio accounts Austin, Texas war m. Sheppard:

the Your requeskfor above subjeot-matter is opinion conoerni.ng

Control. The o approve the aourchase contract
uest by your o&ion ssed your opinion upon contention between the prison rd of Control. with reference the uired to approve thi’s account since contract was based primarily on the issue of installation antInot on the purchas.e of the artiale, WThePrison System contends that sinoe the contract calls for the installation of the maohinery that the Board of Control would not

.*Hon. Gee. H. Sheppard, page 2.

be reqtired to ay,prove the estimates or vouchers before this department would be authorize& to issue warrants in payment thereof..* written Your request npbn which Opinion No. O-2595 ozas

stated:
to IlO We did, tion as *The Stat8 I?oardof Control has refused

approve this aooount for the reason that purchase contraot was let by them.n

. therefore, confine our snswer to the specifio quespresented. Cameron & examfnstion of the si&ed ccntract betzveen

CanGachlnery Companyandthe Texas prison System

. _ . _ ._ _ shozs that the purchase of the machznery contemplated and required the installation of the same. If the contraot had been for installation alone, it might not comewithin the exqlusivo province of thr Board of Control under Article 634of the statutes, but the contraot as awhole is one for the purchase of machinery, such maohinery to bc duly installed, Since the contract embraces a purchase within the meaning of Article 634, Revised Civil Statutes, it was one which could not be let without tho approval of the Board of Control, the installation of such machinery being sn incident to the contract of purchase, but of course anintegral part of the one andonly oontraot entered into. Ihis form of oontroct for purchase obviously is the one favored by the Iexas prison System, for it was executed bythe Cystem.

Fromwhatvtehave said, it follows that the contlYlOt Of FUXhEGU, although it carried with it ane.grecment for installation of the maohinery purchased, should have been madeby the Board of Control instead of bythe Texas Prison System.

Since the purchase including the installment of the machinery aswehave held, was exclusively the provinoe of the Board of Control andsince said purchase presumably is one that should have been madeupon competitive bids Fn aooordanoe with the statutes (Article 634, et seq.), the hoard of Control would have no power to impart validity to the seller’s claim byanapproval of tho audit at this time.

..Eon*.Gee* H. Sheppard, page 3,

por a full discussion of this question see our Opi’$on -ho. O-2612, a copy of which aoconpanies this reply..

The clain should not be passed f?r payment. Yours very truly

mu" We spker Assistant
Exhibit 32.2

STATEMENT PURSUANT TO 18 U.S.C. §1350

        Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Quarterly Report on Form 10-Q for the period endedSeptember 30, 2005 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that theinformation contained in this report fairly presents, in all material respects, the financial condition and results of operations ofMillennium Pharmaceuticals, Inc.

| Dated: November 8, 2005  | /s/  MARSHA H. FANUCCI                  |   |
|-------------------------------|---------------------------------------------------|--------|
|                          |                                                   |   |
|                          | Marsha H. Fanucci                                 |   |
|                          | Senior Vice President and Chief Financial Officer |   |
|                          | (Principal financial officer)                     |   |
|                          |                                              |   |

        A signed original of this written statement required by Section 906 has been provided to MillenniumPharmaceuticals, Inc. and will be retained by Millennium Pharmaceuticals, Inc. and furnished to the Securitiesand Exchange Commission or its staff upon request.
Board of
Directors

    22nd Century
Group, Inc. (f/k/a Touchstone Mining Limited)

    11923 SW
37 Terrace

    Miami, FL
33175

    


    
      	
               
      

            	
              Re:

            	
              Loan
      Forgiveness

            


    

    


    Gentlemen:

    


    On
October 14, 2010 Mark Tompkins made a $50,000 loan (the “Loan”) to 22nd Century
Group, Inc. (formerly known as Touchstone Mining Limited) (the “Company”) which
is represented by a 10% Convertible Promissory Note in the principal amount of
$50,000 made by the Company in favor of Mark Tompkins (the “Note”).

    


    Pursuant
to the term of that certain Agreement and Plan of Merger and Reorganization by
and among Company, 22nd Century
Acquisition Subsidiary, LLC and 22nd Century
Limited, LLC, and in consideration of the transactions contemplated thereby (the
“Merger”), and for other good and valuable consideration, the undersigned hereby
agrees to make a capital contribution of the Note to the Company and in so doing
forgives the entire principal balance of the Loan and the Note, together with
all accrued and unpaid interest thereon. Such contribution and associated
forgiveness shall be effective immediately prior to the closing of the
Merger.

    


    
      
        
          	
                  Very
      truly yours,

                
	 
      
	
                  /s/
      Mark Tompkins

                
	
                  Mark
      Tompkins

                


        

      

    

    


    Date:
January 25, 2011
Exhibit 13.1



ChipMOS TECHNOLOGIES (Bermuda) LTD.



CERTIFICATION



Pursuant to 18 U.S.C. §1350, the undersigned, Shih-Jye Cheng, Chairman and Chief Executive Officer of ChipMOS TECHNOLOGIES (Bermuda) Ltd. (the Company),
hereby certifies, to his knowledge, that the Companys annual report on Form 20-F for the year ended December 31, 2004 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date:    June 29, 2005



/s/ Shih-Jye ChengName:

Shih-Jye ChengTitle:

Chairman and Chief Executive Officer




The foregoing certification is
being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.
[Federal Register Volume 80, Number 15 (Friday, January 23, 2015)]
[Notices]
[Page 3607]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01106]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families

[CFDA Number 93.645]


Correction to the Notice of Allotment Percentages to States for 
Child Welfare Services State Grants

AGENCY: Administration on Children, Youth and Families, Administration 
for Children and Families, Department of Health and Human Services.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Administration on Children, Youth and Families, 
Administration on Children and Families published a document in the 
Federal Register of November 28, 2014, concerning the biennial 
publication of allotment percentages for States under Title IV-B 
subpart 1, Child Welfare Services State Grants Program. The document 
contained an incorrect allotment percentage for the District of 
Columbia.

FOR FURTHER INFORMATION CONTACT: Deborah Bell, Grants Fiscal Management 
Specialist, Office of Grants Management, Office of Administration, 
Administration for Children and Families, telephone (202) 401-4611.
    Correction: In the Federal Register of November 28, 2014, in FR. 
Doc. 2014-28135, on page 70873, in the second column, correct the 
``Allotment Percentage'' for the District of Columbia from ``14.17'' to 
``30.00.''

Melody Wayland,
Senior Grants Policy Specialist, Office of Administration.
[FR Doc. 2015-01106 Filed 1-22-15; 8:45 am]
BILLING CODE 4184-01-P
#### Scott Reynolds SULLIVAN and Willis Wayne West, petitioners, v. UNITED STATES, et al.

No. 82-5229.

Supreme Court of the United States.

*350Nov. 8, 1982.

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit.

Denied.